Literature DB >> 8107226

Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis.

K Hasegawa1, J Huang, S A Rogers, H E Blum, T J Liang.   

Abstract

Hepatitis B virus (HBV) mutants unable to synthesize HBV e antigen have been described in association with fulminant hepatitis. We have cloned and sequenced the entire viral genome of an HBV strain associated with an epidemic of fulminant hepatitis. This strain contained, in addition to two G-to-A mutations in the precore region (nucleotides 1898 and 1901), numerous other mutations in conserved nucleotide positions resulting in significant amino acid substitutions in HBV gene products. We introduced either or both of the two G-to-A mutations into wild-type HBV by oligonucleotide-directed mutagenesis and generated replication-competent constructs of these mutants as well as the fulminant strain. Viral antigen synthesis, transcription, and replication were analyzed after transfection into human hepatoma cells. All viral constructs produced and secreted similar levels of envelope proteins (HBV surface antigen). Analysis of cellular lysate for core-specific immunoreactivity demonstrated a much higher level of core-associated antigens in cells transfected with the fulminant strain. While cells transfected with mutant and wild-type HBV DNAs synthesized similar levels of viral RNAs, the fulminant strain directed the synthesis of a much higher level of core-associated replicative intermediates (as well as virion particles) than the wild type and mutants with either or both of the precore mutations. Increase in the encapsidation of pregenomic RNA into core particles likely the basis for the enhanced replication associated with the fulminant strain. Our study suggests that an HBV mutant with enhanced viral replication may be important in the pathogenesis of fulminant hepatic failure, and mutations other than the precore mutations may be responsible for this variant behavior.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8107226      PMCID: PMC236623     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  Virulence of La Crosse virus is under polygenic control.

Authors:  R S Janssen; N Nathanson; M J Endres; F Gonzalez-Scarano
Journal:  J Virol       Date:  1986-07       Impact factor: 5.103

2.  High affinity monoclonal antibodies to hepatitis B surface antigen (HBsAg) produced by somatic cell hybrids.

Authors:  J R Wands; V R Zurawski
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

3.  Cloning and structural analyses of hepatitis B virus DNAs, subtype adr.

Authors:  A Fujiyama; A Miyanohara; C Nozaki; T Yoneyama; N Ohtomo; K Matsubara
Journal:  Nucleic Acids Res       Date:  1983-07-11       Impact factor: 16.971

4.  Relationship between expression of hepatitis B virus antigens in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic hepatitis B virus infection.

Authors:  N V Naumov; M Mondelli; G J Alexander; R S Tedder; A L Eddleston; R Williams
Journal:  Hepatology       Date:  1984 Jan-Feb       Impact factor: 17.425

5.  Demonstration of two distinct antigenic determinants on hepatitis B e antigen by monoclonal antibodies.

Authors:  M Imai; M Nomura; T Gotanda; T Sano; K Tachibana; H Miyamoto; K Takahashi; S Toyama; Y Miyakawa; M Mayumi
Journal:  J Immunol       Date:  1982-01       Impact factor: 5.422

6.  Subtype ayw variant of hepatitis B virus. DNA primary structure analysis.

Authors:  V Bichko; P Pushko; D Dreilina; P Pumpen; E Gren
Journal:  FEBS Lett       Date:  1985-06-03       Impact factor: 4.124

7.  Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli.

Authors:  F Galibert; E Mandart; F Fitoussi; P Tiollais; P Charnay
Journal:  Nature       Date:  1979-10-25       Impact factor: 49.962

8.  Genetic mapping of lymphocytic choriomeningitis virus pathogenicity: virulence in guinea pigs is associated with the L RNA segment.

Authors:  Y Riviere; R Ahmed; P J Southern; M J Buchmeier; M B Oldstone
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

9.  Complete nucleotide sequence of hepatitis B virus DNA of subtype adr and its conserved gene organization.

Authors:  M Kobayashi; K Koike
Journal:  Gene       Date:  1984-10       Impact factor: 3.688

10.  The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw.

Authors:  Y Ono; H Onda; R Sasada; K Igarashi; Y Sugino; K Nishioka
Journal:  Nucleic Acids Res       Date:  1983-03-25       Impact factor: 16.971

View more
  33 in total

1.  A novel stop codon mutation in HBsAg gene identified in a hepatitis B virus strain associated with cryptogenic cirrhosis.

Authors:  Xu Yang; Xiao-Peng Tang; Jian-Hua Lei; Hong-Yu Luo; Yong-Hong Zhang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

2.  Fatal fulminant hepatitis caused by infection with subgenotype A1 hepatitis B virus with C1766T/T1768A core promoter mutations.

Authors:  Takashi Hoshino; Hitoshi Takagi; Yuhei Suzuki; Atsushi Naganuma; Ken Sato; Satoru Kakizaki; Tsutomu Nishizawa; Hiroaki Okamoto; Masanobu Yamada
Journal:  Clin J Gastroenterol       Date:  2016-05-10

3.  Hepatitis C virus structural proteins assemble into viruslike particles in insect cells.

Authors:  T F Baumert; S Ito; D T Wong; T J Liang
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

Review 4.  Cytotoxic T cells and viral hepatitis.

Authors:  F V Chisari
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

5.  X-deficient woodchuck hepatitis virus mutants behave like attenuated viruses and induce protective immunity in vivo.

Authors:  Z Zhang; N Torii; Z Hu; J Jacob; T J Liang
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

6.  A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency.

Authors:  X Lin; Z H Yuan; L Wu; J P Ding; Y M Wen
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

7.  A novel hepatitis B virus mutant with A-to-G at nt551 in the surface antigen gene.

Authors:  Hua-Biao Chen; De-Xing Fang; Fa-Qing Li; Hui-Ying Jing; Wei-Guo Tan; Su-Qin Li
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

Review 8.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

9.  Clinical efficacy of a 24-months course of lamivudine therapy in patients with HBeAg negative chronic hepatitis B: a long-term prospective study.

Authors:  Yong Han Paik; Ja Kyung Kim; Do Young Kim; Jun Yong Park; Sang Hoon Ahn; Kwang-Hyub Han; Chae Yoon Chon; Kwan Sik Lee
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

10.  Regulation of hepatitis B virus core promoter by transcription factors HNF1 and HNF4 and the viral X protein.

Authors:  Yanyan Zheng; Jie Li; Jing-hsiung Ou
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.